A placebo-controlled trial of isoprinosine in patients with multiple sclerosis

21Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

Isoprinosine was used under double-blind, randomised, and placebo-controlled conditions in 52 patients with relapsing/remitting or progressive multiple sclerosis. All patients received pulsed treatment with methylprednisolone. There was no significant effect of treatment on clinical disability or the accumulation of MRI abnormalities, after correction of results for multiple comparisons. It is concluded that isoprinosine is not effective therapy for multiple sclerosis.

Cite

CITATION STYLE

APA

Milligan, N. M., Miller, D. H., & Compston, D. A. S. (1994). A placebo-controlled trial of isoprinosine in patients with multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry, 57(2), 164–168. https://doi.org/10.1136/jnnp.57.2.164

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free